Publication:
The RADial artery International ALliance (RADIAL) extended follow-up study: Rationale and study protocol

dc.contributor.authorGaudino, Mario (7005592319)
dc.contributor.authorBenedetto, Umberto (13906087500)
dc.contributor.authorFremes, Stephen (7005370948)
dc.contributor.authorBallman, Karla (6701817642)
dc.contributor.authorBiondi-Zoccai, Giuseppe (57209103657)
dc.contributor.authorSedrakyan, Art (55207402200)
dc.contributor.authorNasso, Giuseppe (6602872975)
dc.contributor.authorRaman, Jai (35460854900)
dc.contributor.authorBuxton, Brian (7101750784)
dc.contributor.authorHayward, Philip A (17134822400)
dc.contributor.authorMoat, Neil (57207515942)
dc.contributor.authorCollins, Peter (7402501228)
dc.contributor.authorWebb, Carolyn (7202857888)
dc.contributor.authorPeric, Miodrag (7006618529)
dc.contributor.authorPetrovic, Ivana (35563660900)
dc.contributor.authorYoo, Kyung J (7202592784)
dc.contributor.authorHameed, Irbaz (57207543795)
dc.contributor.authorDi Franco, Antonino (37025809400)
dc.contributor.authorMoscarelli, Marco (8979326800)
dc.contributor.authorSpeziale, Giuseppe (7003720477)
dc.date.accessioned2025-06-12T14:49:07Z
dc.date.available2025-06-12T14:49:07Z
dc.date.issued2019
dc.description.abstractIt is generally accepted that radial artery (RA) grafts have better mid-term patency rate compared to saphenous vein grafts. However, the clinical correlates of the improved patency rate are still debated. Observational studies have suggested increased survival and event-free survival for patients who receive an RA rather than a saphenous vein, but they are open to bias and confounders. The only evidence based on randomized data is a pooled meta-analysis of 6 randomized controlled trial comparing the RA and the saphenous vein published by the RADial artery International Alliance (RADIAL). In the RADIAL database, improved freedom from follow-up cardiac events (death, myocardial infarction and repeat revascularization) was found at 5-year follow-up in the RA arm. The most important limitation of the RADIAL analysis is that most of the included trials had an angiographic follow-up in the first 5 years and it is unclear whether the rate of repeat revascularization (the main driver of the composite outcome) was clinically indicated due to per-protocol angiographies. Here, we present the protocol for the long-term analysis of the RADIAL database. By extending the follow-up beyond the 5th postoperative year (all trials except 1 did not have angiographic follow-up beyond 5 years), we aim to provide data on the role of RA in coronary artery bypass surgery with respect to long-term outcomes. © 2019 The Author(s). Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
dc.identifier.urihttps://doi.org/10.1093/ejcts/ezz247
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85075221290&doi=10.1093%2fejcts%2fezz247&partnerID=40&md5=1d248be842f7367dd11d73f48088c6c4
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/5294
dc.subjectArteries
dc.subjectCoronary artery bypass
dc.subjectMyocardial revascularization
dc.subjectRadial Artery Patency Study
dc.subjectRadial Artery Versus Saphenous Vein Patency trial
dc.titleThe RADial artery International ALliance (RADIAL) extended follow-up study: Rationale and study protocol
dspace.entity.typePublication

Files